April 26th, 2012 tmccoy
by: Stephanie Herschaft, Esq. On April 16th, 2012, Health Canada (the equivalent of the FDA in Canada) in collaboration with Takeda (the manufacturer of Actos) endorsed important safety information about ACTOS (pioglitazone hydrochloride), particularly that there is a potential risk of bladder cancer in patients who are prescribed Actos to help control their diabetes. This [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
April 26th, 2012 tmccoy
by: Jonathan Macri, Esq. Bayer AG, one of the world’s largest and most successful manufacturers of pharmaceuticals, has finally begun to get an idea of just how much their failure to warn users of the dangers of one of their most popular drugs is going to cost them. The company recently announced that settlements in [...]
Posted in Defective Drugs, Latest News by: tmccoy
No Comments
April 26th, 2012 tmccoy
by: Matthew McCauley, Esq. Emergency personnel who first responded to the American tragedy of the World Trade Center were put at a high risk due to exposure to toxic dust and chemicals. These victims, which include loved ones who lost someone, are being compensated by the victims’ compensation fund. Health conditions being compensated for include [...]
Posted in Environmental, Latest News, Personal Injury by: tmccoy
No Comments
